Brca1 Mutation Carrier Withdrawn Phase Trials for Celecoxib (DB00482)

Also known as: BRCA1 Mutation Carrier

IndicationStatusPhase
DBCOND0030677 (Brca1 Mutation Carrier)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00084370Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic OophorectomyPrevention